Radiotherapy for Merkel cell carcinoma: recommendations from the DEGRO Dermatooncology Working Group

Abstract Merkel cell carcinoma (MCC) is a rare malignancy with an annual incidence in Germany of 5.2 per million for men and 3.8 per million for women, predominantly affecting sun-exposed areas in older adults. Despite a frequently unfavorable prognosis, outcomes are multifactorial and depend on tumor site, disease stage, performance status, patient age, sex, and immune competence. The current standard of care prescribes surgical resection followed by adjuvant radiotherapy of the tumor bed, ideally initiated within 8 weeks after surgery to optimize clinical outcomes. In case of lymph node involvement, lymph node dissection and/or radiotherapy of the involved nodal basin are recommended. Furthermore, new evidence supports the effectiveness of shorter radiotherapy approaches, with moderate hypofractionated or even ultrahypofractionated schedules serving as effective options for certain patients, particularly those with frailty or comorbidities, or when it is clinically necessary to minimize the treatment burden. In cases of inoperability, refusal of surgery, or significant frailty, definitive local radiotherapy can achieve sufficient disease control. The synergistic potential of combining immunotherapy with radiation in advanced cases remains a key area for ongoing research.

Authors

Institutions

Publication Details

Journal
Strahlentherapie und Onkologie
Published
2026-09-09
DOI
https://doi.org/10.1007/s00066-026-02587-0
Primary Topic
Polyomavirus and related diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

Radiotherapy for Merkel cell carcinoma: recommendations from the DEGRO Dermatooncology Working Group

Stefanie Corradini, Tina Jost, Eleni Gkika, Kathrin Hering et al.
Strahlentherapie und Onkologie
Polyomavirus and related diseases
article

Radiotherapy for Merkel cell carcinoma: recommendations from the DEGRO Dermatooncology Working Group

Stefanie Corradini, Tina Jost, Eleni Gkika, Kathrin Hering, Ahmed Gawish, Isabel Falke, Laila König, Dirk Vordermark, Alexander Rühle, Siyer Roohani, Khaled Elsayad, Hans Theodor Eich, Maike Trommer, André Glowka, Markus Hecht
article en

Abstract

Abstract Merkel cell carcinoma (MCC) is a rare malignancy with an annual incidence in Germany of 5.2 per million for men and 3.8 per million for women, predominantly affecting sun-exposed areas in older adults. Despite a frequently unfavorable prognosis, outcomes are multifactorial and depend on tumor site, disease stage, performance status, patient age, sex, and immune competence. The current standard of care prescribes surgical resection followed by adjuvant radiotherapy of the tumor bed, ideally initiated within 8 weeks after surgery to optimize clinical outcomes. In case of lymph node involvement, lymph node dissection and/or radiotherapy of the involved nodal basin are recommended. Furthermore, new evidence supports the effectiveness of shorter radiotherapy approaches, with moderate hypofractionated or even ultrahypofractionated schedules serving as effective options for certain patients, particularly those with frailty or comorbidities, or when it is clinically necessary to minimize the treatment burden. In cases of inoperability, refusal of surgery, or significant frailty, definitive local radiotherapy can achieve sufficient disease control. The synergistic potential of combining immunotherapy with radiation in advanced cases remains a key area for ongoing research.

Strahlentherapie und Onkologie
Goethe University Frankfurt (DE), Universität Hamburg (DE), Philipps University of Marburg (DE), Heidelberg University (DE), Universitätsklinikum Gießen und Marburg (DE), University Hospital Bonn (DE), University Hospital Heidelberg (DE), Universitätsklinikum Erlangen (DE), University Hospital Münster (DE), University Medical Center Hamburg-Eppendorf (DE), Klinik und Poliklinik für Strahlentherapie und Radioonkologie (DE), Universitätsklinik für Strahlentherapie (DE), University Hospital Frankfurt (DE), Clemenshospital Münster (DE), University Hospital Magdeburg (DE), Klinik und Poliklinik für Neurologie (DE), University Hospital in Halle (DE), Saarland University (DE)
Good health and well-being
Openalex Percentile: Top 13%
Polyomavirus and related diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.